alexa
Reach Us +44 20 3936 9064

GET THE APP

Chlamydophila Pneumonia | OMICS International
ISSN: 2167-7719
Air & Water Borne Diseases
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Chlamydophila Pneumonia

Mona Z Zaghloul*

Department of Clinical Pathology, Ain Shams University Hospitals, Cairo, Egypt

*Corresponding Author:
Mona Z Zaghloul
Microbiology Unit
Department of Clinical Pathology
Ain Shams University Hospitals, Cairo, Egypt
Tel: 02-24023494
Email: [email protected]

Received Date: May 20, 2015; Accepted Date: May 22, 2015; Published Date: May 26, 2015

Citation: Zaghloul MZ (2015) Chlamydophila Pneumonia. Air Water Borne Diseases 4:e134. doi:10.4172/2167-7719.1000e134

Copyright: © 2015 Zaghloul MZ et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Air & Water Borne Diseases

Editorial

Chlamydophila pneumoniae (formerly Chlamydia pneumonia (is a Gram-negative intracellular bacterium [1] responsible for acute upper and lower respiratory tract infections. The first known case of infection with C. pneumoniae was a case of sinusitis in Taiwan. This atypical bacterium commonly causes pharyngitis, bronchitis, sinusitis [2] and atypical pneumonia [3] not only in elderly and debilitated patients, but also in healthy adults [4]. The term atypical pneumonia was used by Reiman in 1938 to describe the infection of non-characteristic course resistant to sulphonamide therapy [5]. Some researchers used the term “infections with atypical pathogens” to describe infection caused by Chlamydia, Mycoplasma and Legionella [6]. In addition to pneumonia, C. pneumoniae causes extrapulmonary manifestations include nervous system disorders such as Guillain-Baré syndrome and meningoencephalitis as well as atherosclerosis and coronary artery disease [7], reactive arthritis [8] and myocarditis [9].

Specific diagnosis of infection with atypical pathogens is important because treatment with routinely used β-lactam antibiotics is ineffective against these organisms, and atypical pneumonia can sometimes develop a severe clinical course. The isolation of C. pneumoniae in cell cultures as HEp-2 and HL cells require multiple passages over a period of weeks to show a positive result [10]. Failure to isolate the pathogen may be due to inadequate sample, specimen toxicity in cell culture or loss of specimen viability during transportation. Antigen detection tests include direct fluorescent antibody assays (DFA) and enzyme immunoassays (EIA) have the advantage of rapid turnaround time. Diagnosis of acute C. pneumoniae infection is based on paired serum samples obtained 4 to 8 weeks apart showing a 4-fold increase in IgG antibody titer, or on a single sample showing IgM antibody positivity [11]. IgA antibodies may be a marker of persistent infection and has been used in the definition of chronic C. pneumoniae infection [12]. The microimmunofluorescence (MIF) assay developed by Wang et al., [13] is considered the gold standard for Chlamydia serology today. It was proved to be suitable for routine diagnosis [14]. In the MIF test, purified elementary bodies are used to detect Chlamydia-specific antibodies in the IgM, IgG, and IgA serum fractions. The diagnostic criteria were a significant increase in specific antibody titer in paired serum samples, a very high specific IgG antibody titer, or the presence of IgM antibodies against C. pneumoniae [15]. Polymerase chain reaction (PCR) techniques have been developed for the detection of C. pneumoniae DNA [16]. Johansson et al, [17] reported that PCR was more sensitive than conventional microbiological methods and it could help to increase the microbial yield for patients with community acquired pneumonia.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 9376
  • [From(publication date):
    December-2015 - Feb 28, 2021]
  • Breakdown by view type
  • HTML page views : 9232
  • PDF downloads : 144
Top